Could steroids save sight in parasitic eye disease?

NCT ID NCT06213649

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 3 trial tests whether adding steroid eye drops to standard anti-parasitic treatment improves vision in people with acanthamoeba keratitis, a rare but serious eye infection. About 232 participants who still have eye inflammation after one month of standard care will receive either steroid drops or placebo drops for several weeks. The main goal is to see if steroids help achieve better vision and reduce pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
topical corticosteroid (dexamethasone)
What this could lead to
If successful, adding steroids could reduce inflammation and improve vision outcomes for people with this rare eye infection.
What could go wrong
This is a Phase 3 trial, but it only includes people who still have inflammation after 4 weeks of standard treatment. Steroids may also suppress the immune response, potentially worsening the infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACANTHAMOEBA KERATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aravind Eye Hospital

    RECRUITING

    Coimbatore, Tamil Nadu, India

  • Aravind Eye Hospital

    RECRUITING

    Madurai, Tamil Nadu, India

  • Baylor College of Medicine

    RECRUITING

    Houston, Texas, 77030, United States

  • Columbia University

    RECRUITING

    New York, New York, 10032, United States

  • Federal University of São Paulo

    RECRUITING

    São Paulo, Brazil

  • Johns Hopkins University

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • Moorfields Eye Hospital

    RECRUITING

    London, United Kingdom

  • Oregon Health and Science University

    RECRUITING

    Portland, Oregon, 97239, United States

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94158, United States

  • University of Colorado Anschutz

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32605, United States

  • University of Illinois, Chicago

    RECRUITING

    Chicago, Illinois, 60612, United States

  • University of Iowa

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Miami

    RECRUITING

    Miami, Florida, 33136, United States

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • University of Pittsburgh Medical Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15219, United States

  • University of Washington

    RECRUITING

    Seattle, Washington, 98104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.